Speaker

Melissa Palmer, MD

CEO Liver Consulting LLC
CEO Liver Consulting LLC
Melissa Palmer, MD

Biography

Melissa Palmer, MD has been a Hepatologist for over 35 years and is an experienced biotech/pharma executive. She is currently CEO of Liver Consulting LLC, consulting exclusively to biotech and pharmaceutical companies on hepatology-related issues such as: innovative trial designs for all liver diseases including metabolic dysfunction-associated steatotic hepatitis (MASH), Hepatitis B and D, primary sclerosing cholangitis (PSC), all aspects of liver disease drug development from pre-IND to NDA, and hepatic impairment studies. Dr Palmer's specific expertise is in hepatic adverse event (HAE) adjudication and hepatic signal evaluation during clinical trials.

Sessions

7:00 AM - 7:45 AM
Nov 17 2024
San Diego, CA

MTE #16: Cannabis and Cannabidiol Hepatotoxicity (Ticketed)

Acute Liver Failure
Acute-on-Chronic Liver Failure
Drug-Induced Liver Injury
9:45 AM - 10:45 AM
Nov 17 2024
San Diego, CA

Wait Wait... Don't DILI!

Alexandre Louvet, MD, PhD, Presenter
Gina Choi, MD, Presenter
Marwan S Ghabril, MD, Presenter
ALD
Drug-Induced Liver Injury